161 related articles for article (PubMed ID: 37858478)
1. Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors.
Ronot M; Dioguardi Burgio M; Gregory J; Hentic O; Vullierme MP; Ruszniewski P; Zappa M; de Mestier L
Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101827. PubMed ID: 37858478
[TBL] [Abstract][Full Text] [Related]
2. Are recist criteria adequate in assessing the response to therapy in metastatic NEN?
Vullierme MP; Ruszniewski P; de Mestier L
Rev Endocr Metab Disord; 2021 Sep; 22(3):637-645. PubMed ID: 33871762
[TBL] [Abstract][Full Text] [Related]
3. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L; Resche-Rigon M; Dromain C; Lamarca A; La Salvia A; de Baker L; Fehrenbach U; Pusceddu S; Colao A; Borbath I; de Haas R; Rinzivillo M; Zerbi A; Funicelli L; de Herder WW; Selberherr A; Wagner AD; Manoharan P; De Cima A; Lybaert W; Jann H; Prinzi N; Faggiano A; Annet L; Walenkamp A; Panzuto F; Pedicini V; Pitoni MG; Siebenhuener A; Mayerhoefer ME; Ruszniewski P; Vullierme MP
J Neuroendocrinol; 2023 Jun; 35(6):e13311. PubMed ID: 37345276
[TBL] [Abstract][Full Text] [Related]
4. Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.
de Mestier L; Dromain C; d'Assignies G; Scoazec JY; Lassau N; Lebtahi R; Brixi H; Mitry E; Guimbaud R; Courbon F; d'Herbomez M; Cadiot G
Endocr Relat Cancer; 2014 Jun; 21(3):R105-20. PubMed ID: 24351682
[TBL] [Abstract][Full Text] [Related]
5. Peptide receptor therapies in neuroendocrine tumors.
Bodei L; Ferone D; Grana CM; Cremonesi M; Signore A; Dierckx RA; Paganelli G
J Endocrinol Invest; 2009 Apr; 32(4):360-9. PubMed ID: 19636207
[TBL] [Abstract][Full Text] [Related]
6. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
Ambrosini V; Kunikowska J; Baudin E; Bodei L; Bouvier C; Capdevila J; Cremonesi M; de Herder WW; Dromain C; Falconi M; Fani M; Fanti S; Hicks RJ; Kabasakal L; Kaltsas G; Lewington V; Minozzi S; Cinquini M; Öberg K; Oyen WJG; O'Toole D; Pavel M; Ruszniewski P; Scarpa A; Strosberg J; Sundin A; Taïeb D; Virgolini I; Wild D; Herrmann K; Yao J
Eur J Cancer; 2021 Mar; 146():56-73. PubMed ID: 33588146
[TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceuticals used for diagnosis and therapy of NETs.
Papachristou M
Hell J Nucl Med; 2023; 26 Suppl():19-20. PubMed ID: 37658556
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease.
Parghane RV; Ostwal V; Ramaswamy A; Bhandare M; Chaudhari V; Talole S; Shrikhande SV; Basu S
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):913-923. PubMed ID: 32876706
[TBL] [Abstract][Full Text] [Related]
9. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114
[TBL] [Abstract][Full Text] [Related]
10. The RECIST criteria compared to conventional response evaluation after peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms.
Løitegård T; Berntzen DT; Thiis-Evensen E
Ann Nucl Med; 2019 Mar; 33(3):147-152. PubMed ID: 30406360
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead.
Sundin A; Rockall A
Neuroendocrinology; 2012; 96(4):261-71. PubMed ID: 22907438
[TBL] [Abstract][Full Text] [Related]
12. Molecular Imaging and Therapy for Neuroendocrine Tumors.
Desai H; Borges-Neto S; Wong TZ
Curr Treat Options Oncol; 2019 Aug; 20(10):78. PubMed ID: 31468190
[TBL] [Abstract][Full Text] [Related]
13. Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-
Galgano SJ; Iravani A; Bodei L; El-Haddad G; Hofman MS; Kong G
AJR Am J Roentgenol; 2022 May; 218(5):767-780. PubMed ID: 34985313
[TBL] [Abstract][Full Text] [Related]
14. Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors.
Dromain C; Pavel M; Ronot M; Schaefer N; Mandair D; Gueguen D; Cheng C; Dehaene O; Schutte K; Cahané D; Jégou S; Balazard F
Future Oncol; 2023 Oct; 19(32):2171-2183. PubMed ID: 37497626
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hitherto unknown brain meningioma detected on
Parghane RV; Talole S; Basu S
World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
[TBL] [Abstract][Full Text] [Related]
16. Theranostic in Nuclear Medicine - The paradigm of NET.
Giammarile F
Hell J Nucl Med; 2023; 26 Suppl():42-43. PubMed ID: 37658562
[TBL] [Abstract][Full Text] [Related]
17. Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management.
Roll W; Weckesser M; Seifert R; Bodei L; Rahbar K
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4016-4027. PubMed ID: 33903926
[TBL] [Abstract][Full Text] [Related]
18. Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
Parghane RV; Talole S; Prabhash K; Basu S
Clin Nucl Med; 2017 Jun; 42(6):428-435. PubMed ID: 28319500
[TBL] [Abstract][Full Text] [Related]
19. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.
Saleh M; Bhosale PR; Yano M; Itani M; Elsayes AK; Halperin D; Bergsland EK; Morani AC
Abdom Radiol (NY); 2022 Sep; 47(9):3078-3100. PubMed ID: 33095312
[TBL] [Abstract][Full Text] [Related]
20. Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
Nicolini S; Bodei L; Bongiovanni A; Sansovini M; Grassi I; Ibrahim T; Monti M; Caroli P; Sarnelli A; Diano D; Di Iorio V; Grana CM; Cittanti C; Pieri F; Severi S; Paganelli G
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3260-3267. PubMed ID: 33604690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
